Real-world long-term battery longevity of Micra leadless pacemakers

Breeman, Karel; Oosterwerff, Erik; Dijkshoorn, Leonard A; Salavati, Arman; Beurskens, Niek E.G.; Wilde, Arthur A.M.; Delnoy, Peter-Paul; Tjong, Fleur V.Y.; Knops, Reinoud E.

doi:10.1007/s10840-022-01447-y

Cited by 4 publications

(4 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…13 Another study exploring 7-year follow up of leadless pacemakers has demonstrated that the manufacturers anticipated battery life is accurate, and may provide more precise estimates when compared to the battery life predictions of traditional transvenous systems. 14 Despite their utility, leadless devices are not without their shortcomings. The Micra VR device cannot provide atrial pacing, limiting its programming to VVI and VVO.…”

Section: Discussionmentioning

confidence: 99%

“…One analysis has demonstrated equivalence of leadless and transvenous pacemakers over 14 months in reducing syncope frequency amongst 72 patients with a history of cardioinhibitory vasovagal syncope 13 . Another study exploring 7‐year follow up of leadless pacemakers has demonstrated that the manufacturers anticipated battery life is accurate, and may provide more precise estimates when compared to the battery life predictions of traditional transvenous systems 14 …”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Use of a leadless pacemaker in the management of swallow syncope: A case report

Brieger,

Tofler,

Chia

2024

Pacing Clinical Electrophis

View full text Add to dashboard Cite

A 41‐year‐old male presented with syncope whilst eating and was subsequently demonstrated to have recurrent symptomatic sinus pauses whilst swallowing. Following the exclusion of structural heart disease, he was diagnosed with swallow syncope, an uncommon variant of neurocardiogenic syncope. To avoid long‐term complications of a transvenous pacemaker, the case was managed with a leadless pacemaker which resulted in complete resolution of symptoms.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Use of a leadless pacemaker in the management of swallow syncope: A case report

Brieger,

Tofler,

Chia

2024

Pacing Clinical Electrophis

View full text Add to dashboard Cite

show abstract

“…However, the long-term experience with Micra retrieval is limited. The Micra VR was designed with 12 years of battery life, and the battery longevity was confirmed in the real-world setting [ 67 ]. As for the Micra AV, the original design of an 11.8 year battery life (1 V, 0.24 ms) with 100% pacing was reduced to 10.5 years in the real-world setting [ 68 ].…”

Section: Leadless Ventricular Pacemakersmentioning

confidence: 99%

Strategies for Safe Implantation and Effective Performance of Single-Chamber and Dual-Chamber Leadless Pacemakers

Tong

Sun

2023

JCM

View full text Add to dashboard Cite

Leadless pacemakers (LPMs) have emerged as an alternative to conventional transvenous pacemakers to eliminate the complications associated with leads and subcutaneous pockets. However, LPMs still present with complications, such as cardiac perforation, dislodgment, vascular complications, infection, and tricuspid valve regurgitation. Furthermore, the efficacy of the leadless VDD LPMs is influenced by the unachievable 100% atrioventricular synchrony. In this article, we review the available data on the strategy selection, including appropriate patient selection, procedure techniques, device design, and post-implant programming, to minimize the complication rate and maximize the efficacy, and we summarize the clinical settings in which a choice must be made between VVI LPMs, VDD LPMs, or conventional transvenous pacemakers. In addition, we provide an outlook for the technology for the realization of true dual-chamber leadless and battery-less pacemakers.

show abstract

“…konnten in einer Analyse von 153 PatientInnen mit einem Micra TM VR bei einem mittleren Follow-up von 35 Monaten (bis maximal 7 Jahre) nachweisen, dass bei einem Großteil der PatientInnen sogar mit einer Laufzeit von > 13 Jahren (bei einem medianen Stimulationsanteil von 35 % und einer stabilen mittleren Stimulationsreizschwelle von 0,7 V @0,24 ms) gerechnet werden kann. Batterieversagen im Sinne eines unvorhergesehenen signifikanten Abfalls der Batteriekapazität traten nicht auf [ 18 ]. Außerhalb Europas ist bereits derzeit eine Nachfolge-Generation des Micra TM verfügbar, Micra TM VR2 und AV2, die beide nun durch eine größere Batteriekapazität projektierte mediane Laufzeiten von 16,7 Jahren (VR) bzw.…”

Section: Laufzeitunclassified

Sondenlose Herzschrittmacher

Steinwender,

Blessberger,

Saleh

2023

Herzschr Elektrophys

View full text Add to dashboard Cite

ZusammenfassungDie beiden aktuell erhältlichen sondenlosen Schrittmacher weisen in den jeweiligen Zulassungsstudien sowie den zusätzlichen Real-world-Registern eine hohe Effektivität und Sicherheit auf. Im Vergleich zu konventionellen Schrittmachern finden sich niedrigere Langzeit-Komplikationsraten (v. a. im Hinblick auf Sondendislokationen und Systeminfektionen). Zunehmende Evidenz (derzeit größtenteils für den MicraTM [Medtronic, Minneapolis, MN, USA]) zeigt, dass diese Vorzüge auch Bestand haben und daher von einer „dauerhaft guten Lösung“ gesprochen werden kann.

show abstract

Real-world long-term battery longevity of Micra leadless pacemakers

Cited by 4 publications

References 5 publications

Use of a leadless pacemaker in the management of swallow syncope: A case report

Use of a leadless pacemaker in the management of swallow syncope: A case report

Strategies for Safe Implantation and Effective Performance of Single-Chamber and Dual-Chamber Leadless Pacemakers

Sondenlose Herzschrittmacher

Contact Info

Product

Resources

About